ImmuCell Corp. posts loss in second quarter: $295,000
Portland-based animal health products maker ImmuCell Corp. suffered a net loss of $295,000, or 10 cents per share, in the second quarter, the company reported this week.
ImmuCell, a small-cap company that trades on the Nasdaq Capital Markets exchange under the symbol ICCC, increased its quarterly revenue to $1.54 million, compared with $1.37 million a year earlier.
However, the company said it incurred significantly higher expenses for product development and operations during the quarter.
The net loss of $295,000 compares with net income of $6,000, less than 1 cent per share, in the second quarter of 2013.
For sixth straight month, U.S. factory output up in July
U.S. factory output rose for the sixth consecutive month in July, led by a jump in the production of motor vehicles, furniture, textiles and metals.
Manufacturing production rose 1 percent in July compared with the previous month, the Federal Reserve reported Friday. Factory output in June was revised slightly higher to a 0.3 percent increase.
Overall industrial production, which includes manufacturing, mining and utilities, rose 0.4 percent in July, dragged down by a 3.4 percent drop in production at utilities.
Grim world news has failed – so far – to deter investors
Europe appears on the brink of another recession. Islamic militants have seized Iraqi territory. Russian troops have massed on the Ukraine border, and the resulting sanctions are disrupting trade. An Ebola outbreak in Africa and Israel’s war in Gaza are contributing to the gloom.
It has been a grim summer in much of the world. Yet investors in the United States have largely shrugged it off – so far at least.
A big reason is that five years after the Great Recession officially ended, the U.S. economy is showing a strength and durability that other major nations can only envy.
– From news service reports